Green Thumb Industries Inc. (GTBIF)
GTBIF Stock Price Chart
Explore Green Thumb Industries Inc. interactive price chart. Choose custom timeframes to analyze GTBIF price movements and trends.
GTBIF Company Profile
Discover essential business fundamentals and corporate details for Green Thumb Industries Inc. (GTBIF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
14 Jun 2018
Employees
4.90K
Website
https://www.gtigrows.comCEO
Benjamin Kovler
Description
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
GTBIF Financial Timeline
Browse a chronological timeline of Green Thumb Industries Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.03, while revenue estimate is $290.98M.
Earnings released on 6 Aug 2025
EPS came in at -$0.01 falling short of the estimated $0.04 by -125.00%, while revenue for the quarter reached $293.26M , beating expectations by +4.52%.
Earnings released on 7 May 2025
EPS came in at $0.04 falling short of the estimated $0.05 by -20.00%, while revenue for the quarter reached $279.54M , missing expectations by -1.47%.
Earnings released on 26 Feb 2025
EPS came in at $0.04 falling short of the estimated $0.06 by -33.33%, while revenue for the quarter reached $294.32M , beating expectations by +2.13%.
Earnings released on 7 Nov 2024
EPS came in at $0.04 falling short of the estimated $0.06 by -33.33%, while revenue for the quarter reached $286.87M , missing expectations by -0.23%.
Earnings released on 5 Aug 2024
EPS came in at $0.09 surpassing the estimated $0.05 by +80.00%, while revenue for the quarter reached $280.09M , missing expectations by -1.05%.
Earnings released on 8 May 2024
EPS came in at $0.13 surpassing the estimated $0.05 by +160.00%, while revenue for the quarter reached $274.57M , beating expectations by +2.02%.
Earnings released on 28 Feb 2024
EPS came in at $0.01 falling short of the estimated $0.04 by -76.02%, while revenue for the quarter reached $285.92M , beating expectations by +6.00%.
Earnings released on 8 Nov 2023
EPS came in at $0.05 surpassing the estimated $0.04 by +19.30%, while revenue for the quarter reached $275.40M , beating expectations by +2.26%.
Earnings released on 8 Aug 2023
EPS came in at $0.05 matching the estimated $0.05, while revenue for the quarter reached $252.39M , beating expectations by +0.71%.
Earnings released on 3 May 2023
EPS came in at $0.04 falling short of the estimated $0.04 by -9.91%, while revenue for the quarter reached $248.54M , missing expectations by -0.14%.
Earnings released on 28 Feb 2023
EPS came in at $0.05 falling short of the estimated $0.07 by -28.57%, while revenue for the quarter reached $259.27M , beating expectations by +0.96%.
Earnings released on 2 Nov 2022
EPS came in at $0.04 falling short of the estimated $0.06 by -33.33%, while revenue for the quarter reached $261.19M , beating expectations by +2.38%.
Earnings released on 3 Aug 2022
EPS came in at $0.10 surpassing the estimated $0.04 by +181.21%, while revenue for the quarter reached $254.31M , beating expectations by +2.21%.
Earnings released on 4 May 2022
EPS came in at $0.12 surpassing the estimated $0.06 by +100.00%, while revenue for the quarter reached $242.60M , beating expectations by +2.35%.
Earnings released on 1 Mar 2022
EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $243.58M , beating expectations by +2.36%.
Earnings released on 10 Nov 2021
EPS came in at $0.08 falling short of the estimated $0.10 by -20.00%, while revenue for the quarter reached $233.68M , missing expectations by -0.50%.
Earnings released on 11 Aug 2021
EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $221.87M .
Earnings released on 12 May 2021
EPS came in at $0.05 falling short of the estimated $0.08 by -37.50%, while revenue for the quarter reached $194.43M , missing expectations by -27.27%.
Earnings released on 17 Mar 2021
EPS came in at $0.11 surpassing the estimated $0.06 by +83.33%, while revenue for the quarter reached $177.23M .
Earnings released on 11 Nov 2020
EPS came in at $0.04 surpassing the estimated $0.01 by +524.02%, while revenue for the quarter reached $157.10M , missing expectations by -44.44%.
GTBIF Stock Performance
Access detailed GTBIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.